M&G’s Catalyst invests $57mn in SkyCell

SkyCell, the Swiss-based technology company transforming the pharmaceutical supply chain, has completed a $57 million (CHF50 million) financing round with Catalyst, M&G Investments’ $6 billion purpose-led private assets strategy. Catalyst invests in innovative, privately-owned global businesses addressing some of the world’s biggest environmental and social challenges, says a release from SkyCell.